Seres Therapeutics Inc

XNAS:MCRB 3:16:16 PM EDT

14.41

-0.83 (-5.45%)

Market Cap (Intraday)	126.15M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$7.83 Million
Adjusted EPS	$0.46

See more estimates

10-Day MA	$16.44
50-Day MA	$18.45
200-Day MA	$13.93

See more pivots

Seres Therapeutics Inc Stock, XNAS:MCRB

101 Cambridge Park Drive, 4th floor, Cambridge, Massachusetts 02140

United States of America

Phone: +1.617.945.9626

Number of Employees: 233

http://www.serestherapeutics.com

Description

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.